Ministry of Science and Technology: There are currently 17 new crown vaccines in clinical trials

China News Service, February 26.

The State Council Information Office held a press conference on the 26th.

Wu Yuanbin responded that since the outbreak of the new crown pneumonia, the Chinese science and technology community has established a research team for the joint prevention and control mechanism of the State Council led by the Ministry of Science and Technology , focusing on viral etiology, detection technologies and products, clinical treatment and drugs, vaccine research and development, and animal model construction.

In terms of vaccine research and development, Wu Yuanbin pointed out that from the beginning, in order to maximize the success rate of research and development, my country has arranged five technologies for inactivated vaccines, nucleic acid vaccines, recombinant protein vaccines, adenovirus vector vaccines and attenuated influenza virus vector vaccines.

Regarding drug research and development, Wu Yuanbin said that from the beginning, the focus was on strengthening the screening of effective drugs.

In addition, Wu Yuanbin introduced the next steps: First, continue to promote scientific research on epidemic prevention and control, strengthen the research and judgment of the epidemic development trend and risk early warning, accelerate the iterative upgrade of vaccine and antibody drug research and development, detection technology and products, and continue to track virus mutations and The impact on vaccines, drugs, and testing reagents provides strong scientific and technological support for epidemic prevention and control.

The second is to strengthen the long-term layout in the field of life and health.

The third is to accelerate the completion of the shortcomings in pathogenic research and the research and development of high-end medical equipment, so that technological innovation can better protect people's lives and health.